Mohammad Jad Moussa

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 9

Top Topics

Emergency Department

Squamous Cell Carcinoma

Radiation Induced

Top Venues

Current oncology (Toronto, Ont.)

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Marianne Zoghbi, Mohammad Jad Moussa, Jim Dagher, Elio Haroun, Aiham Z Qdaisat, Emad D Singer, Yara E Karam, Sai-Ching Jim Yeung, Patrick S Chaftari
Brain Metastasis in the Emergency Department: Epidemiology, Presentation, Investigations, and Management. Cancers 16 (14) (2024)
Stefan Maksimovic, Nina C Boscolo, Ludovica La Posta, Sergio Barrios, Mohammad Jad Moussa, Emanuela Gentile, Pedro I Pesquera, Wenjiao Li, Jianfeng Chen, Javier A Gomez, Akshay V Basi, Jared K Burks, Christopher Alvarez-Breckenridge, Jianjun Gao, Matthew T Campbell, Eleonora Dondossola
Antiangiogenic tyrosine kinase inhibitors have differential efficacy in clear cell renal cell carcinoma in bone. Cancer research communications (2024)
Mohammad Jad Moussa, Matthew T Campbell, Omar Alhalabi
Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand? Biomedicines 12 (3) (2024)
Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, Sagar A Naik, Vivek Subbiah, Matthew T Campbell, Pavlos Msaouel, Parminder Singh, Omar Alhalabi
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. Current oncology (Toronto, Ont.) 31 (6) (2024)
Marianne Zoghbi, Mohammad Jad Moussa, Jim Dagher, Elio Haroun, Aiham Z Qdaisat, Emad D Singer, Yara E Karam, Sai-Ching Jim Yeung, Patrick S Chaftari
Brain Metastasis in the Emergency Department: Epidemiology, Presentation, Investigations, and Management. Cancers 16 (14) (2024)
Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, Sagar A Naik, Vivek Subbiah, Matthew T Campbell, Pavlos Msaouel, Parminder Singh, Omar Alhalabi
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. Current oncology (Toronto, Ont.) 31 (6) (2024)
Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, Sagar A Naik, Vivek Subbiah, Matthew T Campbell, Pavlos Msaouel, Parminder Singh, Omar Alhalabi
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. Current oncology (Toronto, Ont.) 31 (6) (2024)
Mohammad Jad Moussa, Matthew T Campbell, Omar Alhalabi
Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand? Biomedicines 12 (3) (2024)
Marianne Zoghbi, Mohammad Jad Moussa, Jim Dagher, Elio Haroun, Aiham Z Qdaisat, Emad D Singer, Yara E Karam, Sai-Ching Jim Yeung, Patrick S Chaftari
Brain Metastasis in the Emergency Department: Epidemiology, Presentation, Investigations, and Management. Cancers 16 (14) (2024)